296 related articles for article (PubMed ID: 12374683)
1. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China.
Rashid A; Ueki T; Gao YT; Houlihan PS; Wallace C; Wang BS; Shen MC; Deng J; Hsing AW
Clin Cancer Res; 2002 Oct; 8(10):3156-63. PubMed ID: 12374683
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
[TBL] [Abstract][Full Text] [Related]
3. [Genetic alterations in human malignant tumor].
Tomita S; Muto Y; Kusano T; Toda T
Rinsho Byori; 1999 Jan; 47(1):20-6. PubMed ID: 10067361
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas.
Kim SG; Chan AO; Wu TT; Issa JP; Hamilton SR; Rashid A
Gastroenterology; 2003 May; 124(5):1300-10. PubMed ID: 12730870
[TBL] [Abstract][Full Text] [Related]
5. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of BAT-26 as an indicator of microsatellite instability in gallbladder carcinomas.
Saetta A; Koilakou SV; Michalopoulos NV; Davaris PS
Hepatogastroenterology; 2003; 50(54):1799-802. PubMed ID: 14696408
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
Goggins M; Shekher M; Turnacioglu K; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 1998 Dec; 58(23):5329-32. PubMed ID: 9850059
[TBL] [Abstract][Full Text] [Related]
8. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas.
Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S
Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterisation of six human biliary tract cancer cell lines.
Ku JL; Yoon KA; Kim IJ; Kim WH; Jang JY; Suh KS; Kim SW; Park YH; Hwang JH; Yoon YB; Park JG
Br J Cancer; 2002 Jul; 87(2):187-93. PubMed ID: 12107841
[TBL] [Abstract][Full Text] [Related]
10. Beta-catenin mutations in biliary tract cancers: a population-based study in China.
Rashid A; Gao YT; Bhakta S; Shen MC; Wang BS; Deng J; Fraumeni JF; Hsing AW
Cancer Res; 2001 Apr; 61(8):3406-9. PubMed ID: 11309300
[TBL] [Abstract][Full Text] [Related]
11. [Genetic alterations in biliary tract carcinoma].
Sho M; Nakajima Y
Nihon Rinsho; 2006 Jan; 64 Suppl 1():358-61. PubMed ID: 16457282
[No Abstract] [Full Text] [Related]
12. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations.
Kabbani W; Houlihan PS; Luthra R; Hamilton SR; Rashid A
Mod Pathol; 2002 Jun; 15(6):599-605. PubMed ID: 12065772
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite alterations and K-ras, TGFbetaRII, IGFRII and bax mutations in sporadic cancers of the gastrointestinal tract.
Caligo MA; Ghimenti C; Sensi E; Marchetti A; Bertacca G; Giulianotti PG; Fornaciari G; Bevilacqua G
Oncol Rep; 2000; 7(6):1371-5. PubMed ID: 11032947
[TBL] [Abstract][Full Text] [Related]
14. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
15. K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers.
Itoi T; Takei K; Shinohara Y; Takeda K; Nakamura K; Horibe T; Sanada A; Ohno H; Matsubayashi H; Saito T; Watanabe H
Pathol Int; 1999 Jan; 49(1):30-7. PubMed ID: 10227722
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
[TBL] [Abstract][Full Text] [Related]
17. Mutation of the transforming growth factor-beta type II receptor gene in right-sided colorectal cancer: relationship to clinicopathological features and genetic alterations.
Iacopetta BJ; Welch J; Soong R; House AK; Zhou XP; Hamelin R
J Pathol; 1998 Apr; 184(4):390-5. PubMed ID: 9664904
[TBL] [Abstract][Full Text] [Related]
18. Infrequent microsatellite instability in biliary tract cancer.
Suto T; Habano W; Sugai T; Uesugi N; Kanno S; Saito K; Nakamura S
J Surg Oncol; 2001 Feb; 76(2):121-6. PubMed ID: 11223838
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations involved in the development of gallbladder carcinomas from Greek patients.
Saetta A; Lazaris AC; Michalopoulos NV; Davaris PS
Hepatogastroenterology; 2001; 48(41):1284-8. PubMed ID: 11677947
[TBL] [Abstract][Full Text] [Related]
20. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.
Yoshida S; Todoroki T; Ichikawa Y; Hanai S; Suzuki H; Hori M; Fukao K; Miwa M; Uchida K
Cancer Res; 1995 Jul; 55(13):2756-60. PubMed ID: 7796400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
